Season 2| China: Brad Loncar on Investment Risk and Innovation Drivers in Chinese Biotech Behind Biotech

Brad Loncar Biography

Brad Loncar is a biotechnology industry investor and CEO of Loncar Investments. He is the creator of two Nasdaq-listed biotech focused exchange-traded funds. Brad previously worked in the financial services industry at Franklin Templeton Investments where he was a member of the Management Training Program, and was appointed to serve in a Senior Advisor role at the U.S. Department of the Treasury. He currently writes biotechnology commentary at www.LoncarBlog.com, Nasdaq.com, and contributes opinion pieces to Endpoints News. He’s also the co-host of Biotech Clubhouse, which recaps the week’s biotech news every Sunday at 4pm EST.

On this episode we discussed with Brad:


How he first became interested in China biopharma and his advice for getting ‘smart’ on the industry as a foreign investor.
Key players in the China biopharma ecosystem, including investors as well as founder and company profiles
How investors should think about regulatory and geopolitical risk when it comes to investing in China biotech